Vaccination against Respiratory Syncytial Virus (RSV) will begin on September 25, as it treats the main cause of respiratory tract infections such as bronchiolitis or pneumonia. Since last Thursday, September 15 Parents have begun to receive appointments to vaccinate children under six months of age. The total doses contracted for the 2023-2024 campaign are 63,600, with a total budget of 13.8 million euros. These doses will be administered to all children born from October 1, 2023 to March 31, 2024. Likewise, it will also be administered to all infants born between April 1 and September 30, 2023, those that will be captured at the end of this month.
Besides, It will be administered in children under one year of age with a history of prematurity less than 35 weeks, as well as other infants with very high-risk chronic pathologies who are up to 24 months.
With this immunization, infection by this virus is effectively and safely prevented, a respiratory condition that occurs, above all, during autumn and winter. In this sense, has recommended all parents with children under six months of age to accept the invitation for immunization against RSV. And last year, infections from this virus kept 301 minors hospitalized in Andalusia (during the highest peak that occurred in November).
The Minister of Health and Consumer Affairs of the Government of Andalusia, Catalina García, reported this Friday, together with the general director of Public Health and Pharmaceutical Regulation, Jorge del Diego, that “we are convinced that it will be a relief for concerned parents and relatives.” “Andalusia will administer for the first time the monoclonal antibody against RSV – called Nirsevimab, with the commercial name Beyfortus -. In this way, The autonomous community continues to focus on health prevention, with one of the most advanced vaccination schedules in the national territory.
Along these lines, he has stressed that this measure is added to the annual vaccination against influenza in the child population from 6 months to 5 years (59 months), which started in Andalusia during the 2022-2023 campaign, “with the aim of protecting as much as possible to childhood from the most frequent respiratory pathologies and with greater care.” In the first year of administration of the childhood vaccine, more than 45% of the target population has been reached.
On the other hand, he noted that the General Directorate of Public Health and Pharmaceutical Regulation has incorporated RSV into the Acute Respiratory Infection Sentinel Surveillance Protocol, both in Primary and Hospital Care, thus joining the joint surveillance strategy Covid19/Flu that was established for the 2020-2021 season.
2023-09-16 10:47:50
#Vaccination #Respiratory #Syncytial #Virus #begins #September #Huelva
